Your session is about to expire
← Back to Search
Pembrolizumab for Solid Cancers
Study Summary
This trial is testing if pembrolizumab is safe and effective in preventing cancer recurrence in people who have had surgery to remove a solid tumor.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2024 Phase 2 trial • 57 Patients • NCT03004183Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Pembrolizumab
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any more places available for people in this clinical trial?
"That is accurate. The clinical trial, which was first posted on February 20th, 2019, is still recruiting patients according to the information available on clinicaltrials.gov. There are 9 sites enrolling a total of 10 patients."
Are there other precedents for using Pembrolizumab in medical trials?
"Pembrolizumab was first studied a decade ago at City of Hope. As of now, there are 248 completed studies and 1000 ongoing clinical trials concerning this medication. A great deal of these studies are based in Middletown, New york."
For what illnesses is Pembrolizumab most often prescribed?
"Pembrolizumab is a medication that oncologists often prescribe to treat different types of cancer. It can also be used to manage microsatellite instability high and disease progression after chemotherapy in patients that have unresectable melanoma."
Where are the different places this trial is being conducted?
"According to the latest information, 9 sites are running this trial. 3 of these are Memorial Sloan Kettering locations in Middletown, Uniondale, and Montvale. The other 6 clinical trial sites are based in various other locations."
Share this study with friends
Copy Link
Messenger